Alterity Therapeutics
ATHE · ASX
$2.09−$0.06 (−2.79%)TodayMarket closed ·
Prev close $2.15
ATHE analyst rating
BuyConsensus of 5 analysts over the last 12 months. 100% rate it a buy.
- Strong buy0
- Buy5
- Hold0
- Underperform0
- Sell0
12-month price target · 3 analysts
Average $8.74 (+318.1% upside)
- Low
- $8.65
- Now
- $2.09
- High
- $9.00
Upgrades and downgrades
The latest rating actions, newest first
| Firm | Date | Action | Rating |
|---|---|---|---|
| Lake Street | Sep 15, 2026 | Initiates | Buy |
| Craig-Hallum | Aug 11, 2026 | Initiates | Buy |
| Jones Trading | Jun 30, 2026 | Initiates | Buy |
| Ladenburg Thalmann | Jun 16, 2026 | Initiates | Buy |
| Canaccord Genuity | Dec 17, 2025 | Initiates | Speculative Buy |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.